OXFORD,
England, July 12, 2024 /PRNewswire/
-- Today Theolytics, a clinical stage biotechnology
company harnessing viruses to combat disease, announced that
Charlotte Casebourne Stock, Co-Founder and CEO, has decided to
transition into an advisory role with the company. Mike Grey, Executive Chair of the board of
directors will assume overall leadership responsibility until
further notice.
Charlotte Casebourne Stock shares: "It's been extremely
rewarding leading Theolytics from idea at inception in 2017 to
dosing the first ovarian cancer patient with our lead oncolytic
virus candidate THEO-260 this year. I set out on my entrepreneurial
journey to drive equitable access to healthcare innovation, and to
create sustainable companies. With the progress made, and our
investors' support for Theolytics' lead clinical program, it is the
right time for me to embark on a new chapter, in line with my
personal mission."
Mike Grey commented: "On behalf
of the board and Theolytics' investors we would like to extend our
heartfelt appreciation to Charlotte. Without her, Theolytics
wouldn't be in the strong position the company finds itself in
today. Under Charlotte's leadership, over $40m of dilutive and non-dilutive capital was
raised, and in only seven years the company has advanced into the
clinic. We respect her decision to pursue new entrepreneurial
endeavors, and wish her the very best. I look forward to working
with her as an advisor, alongside Theolytics' Board and team to
execute on the promising strategy defined."
About Theolytics
Theolytics is working to develop next generation oncolytic viral
therapies, pioneering a new approach to develop efficacious,
targeted candidates suitable for systemic intravenous
delivery. The company is focused on the clinical development
of its lead program, with the ambition of providing better outcomes
for patients with ovarian cancer. Theolytics is backed by
international life sciences investors M Ventures, Taiho Ventures,
Epidarex Capital, Oxford Science Enterprises, Sound Bioventures and
The University of Oxford.
Photo -
https://mma.prnewswire.com/media/2455984/Theolytics.jpg
CONTACT: enquiries@theolytics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/charlotte-casebourne-stock-moves-on-from-theolytics-to-next-entrepreneurial-endeavour-302192002.html
SOURCE Theolytics